Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) Non Operating Income (2019 - 2025)

Historic Non Operating Income for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to -$4.0 million.

  • Strata Critical Medical's Non Operating Income fell 37542.66% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256000.0, marking a year-over-year decrease of 10299.1%. This contributed to the annual value of $6.4 million for FY2024, which is 3982.03% down from last year.
  • Per Strata Critical Medical's latest filing, its Non Operating Income stood at -$4.0 million for Q3 2025, which was down 37542.66% from $1.2 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year Non Operating Income high stood at $18.1 million for Q2 2022, and its period low was -$16.5 million during Q2 2021.
  • In the last 5 years, Strata Critical Medical's Non Operating Income had a median value of $1.2 million in 2022 and averaged $1.9 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first crashed by 1731111.11% in 2021, then skyrocketed by 6685000.0% in 2022.
  • Quarter analysis of 5 years shows Strata Critical Medical's Non Operating Income stood at $11.2 million in 2021, then tumbled by 69.33% to $3.4 million in 2022, then plummeted by 80.52% to $669000.0 in 2023, then plummeted by 328.1% to -$1.5 million in 2024, then crashed by 164.42% to -$4.0 million in 2025.
  • Its last three reported values are -$4.0 million in Q3 2025, $1.2 million for Q2 2025, and $4.1 million during Q1 2025.